Stoke Therapeutics, Inc. (STOK) › Shareholders' EquityStoke Therapeutics, Inc. (STOK) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: -$1.29M2018: $105.07M2019: $224.43M2020: $286.08M2021: $217.78M2022: $184.85M2023: $159.56M2024: $229.02M2025: $352.46M$352.46M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$352.46M+53.9%2024$229.02M+43.5%2023$159.56M-13.7%2022$184.85M-15.1%2021$217.78M-23.9%2020$286.08M+27.5%2019$224.43M+113.6%2018$105.07M+8232.2%2017-$1.29M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share